Companies

See how salaries can vary from company to company

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense. Its lead product candidate is Tonmyar (TNX-102 SL), a proprietary low-dose cyclobenzaprine and sublingual tablet as a bedtime administration, which is in Phase III development for the treatment of posttraumatic stress disorder (PTSD) and Fibromyalgia; and Phase II development for the treatment of agitation in Alzheimer's disease. The company is also developing TN... view company details

Internationally accredited by CARF/CCAC, Fitch rated, and neighbor to the Duke University campus and medical center, The Forest at Duke is a vibrant, not-for-profit 501(c)3 continuing care retirement community. Over 800 residents from 38 different states have chosen to call The Forest home since its opening in 1992. Today, 400 people enjoy life at The Forest and over 250 team members are an integral part of their lives. Residents are professors, gardeners, authors, CEOs, community volunteers, opera buffs, engineers, librarians, homemakers, artists - folks from all walks of life who embrace and... view company details

Miragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing proprietary RNA-targeted therapies with a specific focus on microRNAs and their role in diseases where there is a high unmet medical need. Its three lead product candidates include cobomarsen, an inhibitor of miR-155 for treating various blood cancers, such as cutaneous T-cell lymphoma, adult T-cell lymphoma/leukemia, diffuse large B-cell lymphoma, and chronic lymphocytic leukemia; Remlarsen, a replacement for miR-29, a microRNA that is found at abnormally low levels in various patholo... view company details

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe neurological diseases. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1b clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD101 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotempora... view company details

VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing medicines for depression and other central nervous system (CNS) disorders. The company's lead product candidate is AV-101, which is in Phase II development stage, an adjunctive treatment used for major depressive disorder. It also focuses on potential commercial applications of its human pluripotent stem cell (hPSC) technology platform to discover, rescue, develop, and commercialize new chemical entities (NCEs) for CNS and other diseases; and regenerative medicine involving hPSC-d... view company details

Valley Health is a not-for-profit health system dedicated to meeting the medical needs of West Virginia, Maryland, and the Top of Virginia. With award-winning hospitals, advanced medical services, and cutting-edge technology, Valley Health has been recognized as a leader in healthcare services. We care about giving back and bringing together communities to provide the care local residents need. Our system's history goes back to 1903, when our first hospital opened its door with just 36 beds. Now, with a combined 604 inpatient beds, 166 long-term care beds, 5,300 employees, and 500 medical staf... view company details

White Mountains Insurance Group, Ltd., through its subsidiaries, provides insurances services in the United States. The company operates through four segments: HG Global/BAM, NSM, MediaAlpha and Other Operations. The HG Global/BAM segment provides insurance on municipal bonds issued to finance public purposes, such as schools, utilities, and transportation facilities, as well as reinsurance protection services. The NSM segment operates as a general underwriting agency and property administrator for specialty property and casualty insurance to sectors, such as specialty transportation, social s... view company details

Windtree Therapeutics, Inc., a biotechnology company, focuses on developing surfactant therapies for respiratory diseases and other potential applications. Its proprietary technology platform includes a synthetic peptide-containing surfactant (KL4 surfactant) that is structurally similar to endogenous pulmonary surfactant and drug-delivery technologies being developed to enable the noninvasive administration of aerosolized KL4 surfactant. The company's lead development program comprises AEROSURF, a drug/device product that has completed Phase IIb clinical trial to treat respiratory distress sy... view company details

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of immuno-oncology therapies for treating heterogenous solid tumors and unknown antigens. The company develops two immuno-oncology platform technologies, including Sleeping Beauty (SB), which is based on the genetic engineering of immune cells using a non-viral transposon/transposase system to reprogram T-cells outside of the body for infusion; and Controlled IL-12, which delivers interleukin 12 or IL-12, a master regular of the immune system, in a controlled and safe manner to f... view company details

8x8, Inc. provides enterprise cloud communications and customer engagement solutions for small and mid-size businesses, mid-market, and distributed enterprises worldwide. It offers unified communications, team collaboration, conferencing, contact center, analytics, and other services to various business customers on a software-as-a-service (SaaS) model. The company provides 8x8 Virtual Office, a self-contained and end-to-end solution that delivers high quality voice and unified communications-as-a-service; 8x8 Contact Center, a multi-channel cloud-based contact center solution; and 8x8 Meeting... view company details

Astea International Inc. develops, markets, and supports service management software solutions worldwide. It offers Astea Alliance, a service management software that addresses the service lifecycle applications, including lead generation, project quotation, service and billing, and asset retirement; and integrates and optimizes business processes for campaigns, call center, depot repair, field service, logistics, projects, and sales and order processing applications. The company also provides FieldCentrix Enterprise suite, a service management solution that runs on various mobile devices; and... view company details

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer and other diseases in North America, Europe, and the Asia Pacific. It provides BRAFTOVITM (encorafenib) capsules in combination with MEKTOVI (binimetinib) tablets for the treatment of patients with unresectable or metastatic melanoma with a BRAF mutation. The company's lead clinical programs include encorafenib and binimetinib that are investigated in approximately 30 clinical trials for various solid tumor indications, including ... view company details

Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally. The company offers turnkey packaging and test services, including semiconductor wafer bumps, wafer probes, wafer back-grinds, package design, packaging, and test and drop shipment services. Its packages employ wirebond, flip chip, copper clip, and other interconnect technologies. The company also provides semiconductor testing services, such as wafer and final test services; flip chip scale package products for use in smartphones, tablets, and other mobile consumer ele... view company details

Altra Industrial Motion Corp. designs, produces, and markets a range of electromechanical power transmission motion control products for use in motion related applications, and high-volume manufacturing and non-manufacturing processes worldwide. It operates in two segments, Power Transmission Technologies and Automation & Specialty. The Power Transmission Technologies segment offers couplings, such as gear couplings, diaphragm and disc couplings, elastomeric couplings, miniature and precision couplings, joints, mill spindles, and shaft locking devices under the Ameridrives, Bibby, Guardian, Hu... view company details

Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke; and that is in Phase II clinical study for the treatment of pati... view company details

AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes a portfolio of targeted medicines for oncology and other areas of unmet medical need. It markets its lead candidate, tivozanib, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC). The company has also completed a Phase 3 TIVO-3 trial of tivozanib for the treatment of RCC; and initiated enrollment in a phase Ib/II clinical trial of tivozanib in combination with Opdivo (nivolumab), an immune checkpoint (PD-1) i... view company details

Started with nothing more than a vision and an entrepreneurial spirit, AmeriLux International was formed in May 2004. AmeriLux is a value-adding distributor of multiwall and corrugated polycarbonate sheet products, PVC sheet and liner panels, and steel coil. Headquartered in De Pere, Wisconsin, AmeriLux sources and distributes materials from and to companies around the world. It is by building and maintaining strategic, win-win partnerships with vendors, customers, and employees that AmeriLux is able to profitably - and sustainably - grow its business. With an emphasis on customer service and ... view company details

Established in 1926, APi Distribution is the leading supplier of commercial, industrial, residential and oil & gas insulation products in the Upper Midwest. APi Distribution, a division of APi, Inc. and part of APi Group Inc., has a proud history of supplying high quality insulation and other construction-related materials to the midwest's finest contractors. We inventory a wide range of insulating products to help control temperature, save energy, and attenuate sound. Our product line includes fiberglass, ceramic blanket, mineral wool, closed cell, calcium silicate, air handling, jacketing (M... view company details

Black Knight, Inc. provides integrated software, data, and analytics solutions to the mortgage and consumer loan, real estate, and capital market verticals in the United States. Its Software Solutions segment offers software and hosting solutions comprises MSP, a software as a service application platform for mortgage and home equity loans that automates various areas of loan servicing; Bankruptcy / Foreclosure solutions for managing and automating a range of different workflow processes involving distressed and non-performing loans; Invoicing, a Web-based solution that helps servicers to save... view company details

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. Its lead product candidate includes KORSUVA (CR845/ difelikefalin) injection, which is in Phase III clinical trial for the treatment of patients with chronic kidney disease (CKD) associated pruritus undergoing hemodialysis, as well as in Phase II/... view company details